pramipexole


Also found in: Medical, Wikipedia.

pram·i·pex·ole

 (prăm′ə-pĕk′sōl′)
n.
A dopamine agonist used in the treatment of Parkinson's disease.

[pr(opyl) + ami(no) + pex-, of unknown meaning + (thiaz)ole.]
Translations

pramipexole

n pramipexol m
References in periodicals archive ?
I tried remedies including tonic water, massage, cold compresses and the prescription medications pramipexole and quinine to control the condition, but nothing seemed to help.
In contrast, dopamine agonism caused by certain drugs such as L-dopa, amphetamine, and pramipexole is associated with increased sexual desire and sexual arousal, which are reported by the patients as increased sexual fantasies, erections, and sexual activities (8).
Camber Pharmaceuticals has added Clopidogrel and Pramipexole Dihydrocloride tablets to its growing portfolio.
added clopidrogrel and pramipexole dihydrocloride tablets to its portfolio.
Reddy's unveils PRAMIPEXOLE Dihydrochloride Extended-Release Tablets in the US market
Thirty patients (aged 20-80 years; mean age, 56 years) with restless legs syndrome and a low-normal serum ferritin level (15-50 ng/ml; suggestive of low or borderline-low iron status) were randomly assigned to receive ferrous sulfate (325 mg twice a day) or pramipexole (0.
Besides, the Nurr1 expression in cultured PBMC was measured to determine whether DA agonist pramipexole affects its mRNA level.
Major finding: The proportional reporting ratio, similar to the relative risk ratio, was significant between pramipexole, ropinirole, cabergoline, bromocriptine, rotigotine, and apomorphine on one hand, and a variety of impulse control disorders on the other.
Multiple agents including dopamine agonists such as carbidopa/levadopa, ropinirole, and pramipexole as well as gabapentin, clonazepam, and opioids have been used in the management of RLS symptoms.
Oral iron supplementation and the dopamine-inhibiting drug pramipexole are equally effective for treating patients with restless legs syndrome and work along similar time frames, South Korean research shows.
To date, 34 technology transfer partnerships between public and private laboratories have been agreed upon for the production of 28 drugs (including Pramipexole, Tenofovir, Clozapine, Quetiapine, Olanzapine, Tacrolimus, Rivastigmine, and Donepezil), and three vaccines.
For this purpose pramipexole, a D2/D3 agonist and trihexiphenidyle, an antimuscarinic agent were selected respectively.